Your request to link to rcsb for Peroxisome proliferator-activated receptor

• 1GWX: molecular recognition of fatty acids by peroxisome proliferator-activated receptors (10.1016/S1097-2765(00)80467-0 )
• 1Y0S: crystal structure of ppar delta complexed with gw2331 (10.1210/ME.14.5.733 )
• 2AWH: human nuclear receptor-ligand complex 1 (10.1016/J.JMB.2005.12.047 )
• 2B50: human nuclear receptor-ligand complex 2 (10.1016/J.JMB.2005.12.047 )
• 2BAW: human nuclear receptor-ligand complex 1 (10.1016/J.MOLCEL.2005.12.001 )
• 2ENV: solution structure of the c4-type zinc finger domain from human peroxisome proliferator-activated receptor delta
• 2GWX: molecular recognition of fatty acids by peroxisome proliferator-activated receptors (10.1016/S1097-2765(00)80467-0 )
• 2J14: 3,4,5-trisubstituted isoxazoles as novel ppardelta agonists: part2 (10.1016/J.BMCL.2006.08.052 )
• 2Q5G: ligand binding domain of ppar delta receptor in complex with a partial agonist (10.1016/J.BMCL.2007.05.079 )
• 2XYJ: novel sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (ppar) gamma-delta agonists with high potency and in-vivo efficacy (10.1002/CMDC.201100047 )
• 2XYW: novel sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (ppar) gamma-delta agonists with high potency and in-vivo efficacy (10.1002/CMDC.201100047 )
• 2XYX: novel sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (ppar) gamma-delta agonists with high potency and in-vivo efficacy (10.1002/CMDC.201100047 )
• 2ZNP: human ppar delta ligand binding domain in complex with a synthetic agonist tipp204 02-mar-16 2znp 1 title (10.1107/S0907444909015935 )
• 2ZNQ: human ppar delta ligand binding domain in complex with a synthetic agonist tipp401 02-mar-16 2znq 1 title (10.1107/S0907444909015935 )
• 3D5F: crystal structure of ppar-delta complex
• 3DY6: ppardelta complexed with an anthranilic acid partial agonist (10.1016/J.BMCL.2008.08.011 )
• 3ET2: structure of ppardelta with 3-[5-methoxy-1-(4-methoxy- benzenesulfonyl)-1h-indol-3-yl]-propionic acid (10.1073/PNAS.0811325106 )
• 3GWX: molecular recognition of fatty acids by peroxisome proliferator-activated receptors (10.1016/S1097-2765(00)80467-0 )
• 3GZ9: crystal structure of peroxisome proliferator-activated receptor delta (ppard) in complex with a full agonist (10.1016/J.BMCL.2009.04.151 )
• 3OZ0: ppar delta in complex with azppard02 (10.1016/J.BMCL.2010.10.117 )
• 3PEQ: ppard complexed with a phenoxyacetic acid partial agonist (10.1016/J.BMCL.2011.02.077 )
• 3SP9: structural basis for iloprost as a dual pparalpha/delta agonist (10.1074/JBC.M111.266023 )
• 3TKM: crystal structure ppar delta binding gw0742 (10.1371/JOURNAL.PONE.0033643 )
• 5U3Q: human ppardelta ligand-binding domain in complexed with specific agonist 1 (10.1073/PNAS.1621513114 )
• 5U3R: human ppardelta ligand-binding domain in complexed with specific agonist 2 (10.1073/PNAS.1621513114 )
• 5U3S: human ppardelta ligand-binding domain in complexed with specific agonist 3 (10.1073/PNAS.1621513114 )
• 5U3T: human ppardelta ligand-binding domain in complexed with specific agonist 4 (10.1073/PNAS.1621513114 )
• 5U3U: human ppardelta ligand-binding domain in complexed with specific agonist 5 (10.1073/PNAS.1621513114 )
• 5U3V: human ppardelta ligand-binding domain in complexed with specific agonist 6 (10.1073/PNAS.1621513114 )
• 5U3W: human ppardelta ligand-binding domain in complexed with specific agonist 7 (10.1073/PNAS.1621513114 )
• 5U3X: human ppardelta ligand-binding domain in complexed with specific agonist 8 (10.1073/PNAS.1621513114 )
• 5U3Y: human ppardelta ligand-binding domain in complexed with specific agonist 9 (10.1073/PNAS.1621513114 )
• 5U3Z: human ppardelta ligand-binding domain in complexed with specific agonist 10 (10.1073/PNAS.1621513114 )
• 5U40: human ppardelta ligand-binding domain in complexed with specific agonist 15 (10.1073/PNAS.1621513114 )
• 5U41: human ppardelta ligand-binding domain in complexed with specific agonist 16 (10.1073/PNAS.1621513114 )
• 5U42: human ppardelta ligand-binding domain in complexed with specific agonist 11 (10.1073/PNAS.1621513114 )
• 5U43: human ppardelta ligand-binding domain in complexed with specific agonist 12 (10.1073/PNAS.1621513114 )
• 5U44: human ppardelta ligand-binding domain in complexed with specific agonist 13 (10.1073/PNAS.1621513114 )
• 5U45: human ppardelta ligand-binding domain in complexed with specific agonist 14 (10.1073/PNAS.1621513114 )
• 5U46: human ppardelta ligand-binding domain in complexed with gw501516 (10.1073/PNAS.1621513114 )
• 5XMX: co-crystal structure of inhibitor compound in complex with human ppardelta lbd (10.1016/J.BMCL.2017.10.037 )
• 5Y7X: human peroxisome proliferator-activated receptor (ppar) delta in complexed with a potent and selective agonist
• 5ZXI: co-crystal structure of an inhibitor in complex with human ppardelta lbd (10.1021/ACSMEDCHEMLETT.8B00287 )
• 6A6P: crystal structure of peroxisome proliferator-activated receptor delta (ppard)lbd in complex with dn003316
• 7VWE: human peroxisome proliferator-activated receptor (ppar) delta ligand binding domain in complex with a synthetic partial agonist jk122 (10.1107/S2053230X22000449 )
• 7VWF: human peroxisome proliferator-activated receptor (ppar) delta ligand binding domain in complex with a synthetic agonist tipp204 (10.1107/S2053230X22000449 )
• 7VWG: human peroxisome proliferator-activated receptor (ppar) delta ligand binding domain in complex with a synthetic alpha/delta dual agonist jkpl38 (10.1107/S2053230X22000449 )
• 7VWH: human peroxisome proliferator-activated receptor (ppar) delta ligand binding domain in complex with a synthetic agonist jkpl39 (10.1107/S2053230X22000449 )
• 7W0G: human ppar delta ligand binding domain in complex with a synthetic agonist h11 (10.1021/ACS.JMEDCHEM.1C02002 )